![Alex Zisson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alex Zisson
Direktor/Vorstandsmitglied bei
AUSPEX PHARMACEUTICALS INC
Profil
Alexendar Henry Zisson is currently Director at Taconic Biosciences, Inc. since 2019; Independent Non-Executive Director at Auspex Pharmaceuticals, Inc. since 2013; Director at BioVectra, Inc.; Director at On Target Laboratories, Inc.; Director at Orbus Therapeutics, Inc. since 2021; Director at Neurana Pharmaceuticals, Inc.; Director at Arvelle Therapeutics International GmbH; Director at Leiters, Inc.; Director at Denver Solutions LLC; and Director at Navitas Life Sciences, Inc. Former roles include Managing Director at Hambrecht & Quist Group from 1997 to 2002; Managing Director at JPMorgan Chase & Co. from 2001 to 2002; Director at Clarus Therapeutics, Inc.; Director at Health Sciences North Research Institute; Independent Director at Clarus Therapeutics Holdings, Inc. from 2021 to 2022; Managing Director at H.I.G.
BioHealth Partners LLC from 2016 to 2026; and Partner at Thomas, McNerney & Partners LLC from 2002 to 2016.
Education includes an undergraduate degree from Brown University conferred in 1991.
Aktive Positionen von Alex Zisson
| Unternehmen | Position | Beginn |
|---|---|---|
| AUSPEX PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 17.10.2013 |
On Target Laboratories LLC
 On Target Laboratories LLC BiotechnologyHealth Technology Discovers, develops and commercializes small molecules that target pathological cells | Direktor/Vorstandsmitglied | - |
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops products that treat rare diseases | Direktor/Vorstandsmitglied | 01.05.2021 |
Leiters, Inc.
 Leiters, Inc. Pharmaceuticals: MajorHealth Technology Manufactures sterile drug compounds | Direktor/Vorstandsmitglied | - |
Denver Solutions LLC
 Denver Solutions LLC Pharmaceuticals: MajorHealth Technology Engages in sterile pharmaceutical manufacturing, repackaging and compounding services | Direktor/Vorstandsmitglied | - |
BioVectra, Inc.
 BioVectra, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization that specializes in clinical-to-commercial scale production for biologics, small molecules, bioreagents and lipids | Direktor/Vorstandsmitglied | - |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Direktor/Vorstandsmitglied | - |
Arvelle Therapeutics International GmbH
 Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Develops and commercializes therapeutic for patients suffering from CNC disorders | Direktor/Vorstandsmitglied | - |
Taconic Biosciences, Inc.
 Taconic Biosciences, Inc. BiotechnologyHealth Technology Develops genetically engineered rodent models and humanized immune system mice for immuno-oncology, immunology, neuroscience and metabolic disease research | Direktor/Vorstandsmitglied | 09.02.2019 |
| ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Alex Zisson
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ ░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Alex Zisson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
Hambrecht & Quist Group, Inc.
 Hambrecht & Quist Group, Inc. Investment Banks/BrokersFinance Operates as a holding investment bank and provides securities brokerage services | Finance |
JPMorgan Chase & Co.
 JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taconic Biosciences, Inc.
Taconic Biosciences, Inc. BiotechnologyHealth Technology Develops genetically engineered rodent models and humanized immune system mice for immuno-oncology, immunology, neuroscience and metabolic disease research | Health Technology |
Thomas, McNerney & Partners LLC
 Thomas, McNerney & Partners LLC Investment ManagersFinance TMT invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technology. It participates in restructuring transactions including spin-outs, roll ups and recapitalizations with an investment size of USD 5 - 40 million. | Finance |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
BioVectra, Inc.
BioVectra, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization that specializes in clinical-to-commercial scale production for biologics, small molecules, bioreagents and lipids | Health Technology |
H.I.G. BioHealth Partners LLC
 H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners invests in companies located in the United States. The firm targets companies operating in the field of medical devices, biopharmaceuticals, digital health, tool & diagnostics and product related services. It provides financing for acquisition, IPO and growth stage capital requirements in the form of equity and debt. It also makes follow on investments. | Finance |
On Target Laboratories LLC
On Target Laboratories LLC BiotechnologyHealth Technology Discovers, develops and commercializes small molecules that target pathological cells | Health Technology |
Health Sciences North Research Institute
 Health Sciences North Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in the research of infections, immunity and cancer solutions | Commercial Services |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops products that treat rare diseases | Health Technology |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Health Technology |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Develops and commercializes therapeutic for patients suffering from CNC disorders | Health Technology |
Leiters, Inc.
Leiters, Inc. Pharmaceuticals: MajorHealth Technology Manufactures sterile drug compounds | Health Technology |
Denver Solutions LLC
Denver Solutions LLC Pharmaceuticals: MajorHealth Technology Engages in sterile pharmaceutical manufacturing, repackaging and compounding services | Health Technology |
Navitas Life Sciences, Inc.
 Navitas Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical development, medical advisory and marketing services of the product | Commercial Services |
Clarus Therapeutics Holdings, Inc.
 Clarus Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops oral T-replacement therapies | Health Technology |
